Related Experiment Videos
Testing for interaction in studies of noninferiority
Brian L Wiens1, Joseph F Heyse
1Amgen Inc., Thousand Oaks, California 93120-1799, USA. bwiens@amgen.com
Journal of Biopharmaceutical Statistics
|March 15, 2003
Summary
This study explores interaction tests for active-controlled clinical trials assessing treatment noninferiority across subgroups. It presents five strategies for testing treatment effect heterogeneity, noting their low power and exploratory use.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Pharmacoeconomics
Background:
- Active-controlled clinical trials aim to establish noninferiority of new treatments versus standard ones.
- Stratification of subjects (e.g., by site, demographics) is common, leading to interest in stratum-specific noninferiority.
Purpose of the Study:
- To evaluate interaction tests for assessing heterogeneity of treatment effects in noninferiority trials.
- To present and compare five distinct analysis strategies for testing treatment effect differences across strata.
Main Methods:
- The study proposes five analysis strategies, adapted from those used for superiority trials.
- Simulation studies are conducted to quantify power and Type I error rates under various scenarios.
- An illustrative example demonstrates the application of the proposed tests.
Main Results:
- The power of interaction tests in noninferiority trials is generally low.
- No single analysis strategy is universally optimal across all parameter configurations.
- The proposed tests are most suitable for descriptive or exploratory purposes.
Conclusions:
- Interaction tests can be adapted for noninferiority trials to explore treatment effect heterogeneity.
- The choice of strategy depends on specific trial parameters and objectives.
- Extensions to equivalence testing are also considered, highlighting the nuanced application of these statistical tools.